Clinical trial
A Phase II Open-Labeled Study to Evaluate CardioPET™ as a PET Imaging Agent for Evaluation of Myocardial Perfusion and Fatty Acid Uptake in Subjects With Coronary Artery Disease
NCT01826773 is registered in ClinicalTrials.gov with Fluoropharma, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Open-Labeled Study to Evaluate CardioPET™ as a PET Imaging Agent for Evaluation of Myocardial Perfusion and Fatty Acid Uptake in Subjects With Coronary Artery Disease
- Lead sponsor
- Fluoropharma, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2013
- Completion date
- September 30, 2016
- Enrollment
- 34 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.